GWPH News and Press, GW Pharmaceuticals Plc From 11/05/19

GW Pharmaceuticals (NASDAQ: GWPH ) Q3 results : More news on: GW Pharmaceuticals plc, Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...

GW Pharmaceuticals (NASDAQ: GWPH ): Q3 GAAP EPS of -$0.04 beats by $0.03 . Revenue of $90.97M (+3690.4% Y/Y) beats by $2.36M . Shares -6.5% . Press Release More news on: GW Pharmaceuticals plc, Earnings news and commentary, Healthcare stocks news,

- Epidiolex U.S. year to date net sales of $188.0 million, including Q3 net sales of $86.1 million - - Conference call today at 4:30 p.m. ET - CARLSBAD, Calif., Nov. 05, 2019 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the ...

GW Pharmaceuticals (NASDAQ: GWPH ) is scheduled to announce Q4 earnings results on Tuesday, November 5th, after market close. The consensus EPS Estimate is -$0.06 (+73.9% Y/Y) and the consensus Revenue Estimate is $88.61M. Over the last 1 year, GWPH  has beaten EPS estimates 0% o...

While Canada may be leading the field in terms of fully legal cannabis, Europe’s CBD market is quietly setting out its stall for a huge future. Analysts at the Brightfield Group predict the CBD market across the Atlantic to soar from $318 million USD in 2018 to $416 million USD thi...

GW Pharmaceuticals (NASDAQ: GWPH ) will be announcing its Q3 results on November 3rd. The stock price tends to tick upwards after earnings. This could be an opportunity to buy the stock at a discount. The stock price has been hit recently by factors not directly connected with its own perfor...

GW Pharmaceuticals (NASDAQ: GWPH) , a U.K.-based company, is a biotech that has pioneered the medical cannabis field and is capitalizing on its first-mover advantage. Founded in 1998, biotech veterans Dr. Geoffrey Guy and Dr. Brian Whittle worked closely with U.K. regulatory agencies ...

Axonics Modulation Technologies (NASDAQ: AXNX ) initiated with Overweight rating and $43 (110% upside) price target at Barclays. More news on: Axonics Modulation Technologies, Inc., GW Pharmaceuticals plc, ShockWave Medical, Inc., Healthcare stocks news, Stocks on the move, , Read more...

October 15, 2019 Palm Beach, FL – October 15, 2019 — Over the next three days, Canada will legalize CBD all over again.  Just a year after legalizing dried cannabis flower, oils, and sprays, Canada will now legalize edibles, beverages, and topicals this Thursday...

Stock investors are a picky and often hard-to-please group. With their money they can punish a company for mistakes and transgressions or for not performing as well as they think it should. But in their zeal to sock it to companies that have done wrong, investors frequently oversell a stock. Th...